Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evolution of IGF-1 in Children Born Small for Gestational Age and With Growth Retardation, Treated by Genotonorm Especially Evolution After Dose Adaptation.

NCT00174252 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT00174252
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00174252 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evolution of IGF-1 in Children Born Small for Gestational Age and With Growth Retardation, Treated by Genotonorm Especially Evolution After Dose Adaptation.
Lead sponsor
Pfizer
Phase
Phase 3
Overall status
Completed
Start date
February 28, 2005
Completion date
April 30, 2009
Enrollment
57 (actual)
Sites
22

Conditions

As the registry lists them; a condition with its own page is linked.

fetal growth retardation